Trials / Completed
CompletedNCT05071872
PMCF of Rotarex®S & Aspirex®S Catheters in Treating Thrombotic Occlusion of Arteriovenous Graft
Retrospective Post-Market Clinical Follow Up of Rotarex®S & Aspirex®S Catheters in Treating Thrombotic Occlusion of Arteriovenous Graft for Dialysis Access (Artificial Bypass)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 127 (actual)
- Sponsor
- Straub Medical AG · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Retrospective Post-Market Clinical Follow Up of Rotarex®S \& Aspirex®S Catheters in treating thrombotic occlusion of Arteriovenous Graft for dialysis access (Artificial Bypass)
Detailed description
To evaluate the safety, technical performance, and clinical efficacy of the Rotarex®S \& Aspirex®S Catheters as a stand-alone and adjunctive therapy for the treatment of acute thrombotic occlusion of arteriovenous graft for dialysis access (Artificial Bypass) in accordance with Rotarex®S \& Aspirex®S Catheters intended use.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Atherectomy/Thrombectomy | Percutaneous transluminal removal of thrombotic occlusion in arteriovenous graft |
Timeline
- Start date
- 2021-10-06
- Primary completion
- 2022-06-08
- Completion
- 2022-06-08
- First posted
- 2021-10-08
- Last updated
- 2023-02-09
Locations
1 site across 1 country: Czechia
Source: ClinicalTrials.gov record NCT05071872. Inclusion in this directory is not an endorsement.